Senate Democrats are facing a competitive race for the party’s leader in the chamber after they won a majority in this month’s midterm elections—and the two contenders both support marijuana reform, though they have taken different approaches to emphasizing the issue.
Current Senate Minority Leader Chuck Schumer (D-NY) has sponsored several bills to federally legalize cannabis but has faced criticism from advocates for not devoting floor time to passing major marijuana reform proposals during his last stint as majority leader, including bipartisan legislation to increase the industry’s access to banking services.
Sen. Chris Van Hollen (D-MD), who is challenging Schumer for the leadership role, has cosponsored and voted for a number of marijuana amendments and bills but has not proactively played a major role in advancing cannabis reform. He has not, for example, joined other Democrats in signing on to the federal legalization proposals that Schumer has championed—but he has separately called for cannabis to be descheduled.
Here’s a look at where the Senate Democratic leadership candidates stand on cannabis:
Sen. Chuck Schumer (D-NY)
Along with other Democratic senators, Schumer has repeatedly filed comprehensive bills to federally legalize, tax and regulate marijuana—introducing the Cannabis Administration and Opportunity Act (CAOA) this year and in 2022 and 2024.
He also sponsored an earlier federal legalization bill called the Marijuana Freedom and Opportunity Act in 2018 and 2019.
Schumer has additionally cosponsored narrower legislation to protect people acting in accordance with medical cannabis laws from federal enforcement, increase the marijuana industry’s access to banking services and legalize industrial hemp. He has additionally, however, cosponsored a youth online safety bill that could create complications for advertisers trying to promote legal marijuana and other regulated substances.
Last year, Schumer voted against a motion to table an amendment that would have removed provisions from spending legislation to federally recriminalize hemp THC products, This year, he supported a motion to table an amendment that would have stripped language from a different bill to delay the implementation of the hemp ban.
In his capacity as Senate majority leader the last time Democrats controlled the chamber, Schumer repeatedly expressed support for a marijuana banking bill that cleared committee but he ultimately never brought it to the floor—drawing harsh criticism from cannabis industry advocates.
The senator and his allies, however, have placed the blame on a lack of support from Republican leaders whose cooperation is often needed to shepherd legislation forward under the body’s rules.
The senator told Marijuana Moment in a 2021 interview that his strategy at that point was move cannabis banking legislation “together” with broader legalization because the financial-focused reform “brings in some people who might not normally support legalization, and we want to get as broad a coalition as possible.”
“We certainly think that we ought to make sure that the communities that have been most affected by these draconian laws get the benefits here, and we want to make sure that there are reinvestment initiatives and it doesn’t all go to the big shots, that smaller businesses and minority businesses get a chance to be involved once marijuana is legalized,” he said. “We want to make sure, A) that they go together and B) that this just doesn’t let all the bankers, the big boys, in without taking into account that communities of color have paid the greatest price here and should get some recompense.”
Schumer had also often discussed his desire to pair the cannabis banking bill with provisions to facilitate expungements of prior marijuana convictions to address the concerns of Democratic colleagues and advocates who did not want to advance an industry-focused reform without addressing criminal justice issues, but such a package never materialized.
In 2023, Schumer attempted to bring a veterans-focused marijuana research bill to the Senate floor for passage but was blocked by Republicans.
“Our veterans need it. It was supported by all of our veterans groups. It had bipartisan, unanimous support in committee,” he said. “I hope that some of our members on the other side of the aisle who didn’t vote for it will reconsider.”
One limited marijuana reform that Schumer did get over the finish line as majority leader in 2022 is a bill aimed at easing barriers to conducting research on marijuana and cannabinoids that was ultimately signed into law by then-President Joe Biden.
The legislation “would eliminate the red tape that hinders cannabis research, opening the door for new innovative treatments derived from cannabis,” Schumer said on the Senate floor. “If you’re one of the millions of Americans who deals with conditions like Parkinson’s or epilepsy or post-traumatic stress, or any number of other conditions, cannabis might hold promising new options for managing these diseases.”
“We need to do the research first,” he said. “And the federal government, sadly, has been woefully behind the times on this front. This bill will help fix that.”
Schumer also helped to shape cannabis laws in his home state of New York, weighing in at a crucial time in 2021 as lawmakers and then-Gov. Andrew Cuomo (D) were negotiating the details of what would ultimately become the state’s recreational marijuana legalization law.
Days ahead of crucial legislative votes, the U.S. senator issued a statement siding with lawmakers’ cannabis plan, which was seen as much more focused on racial justice and equity than the one the governor had included in his budget proposal.
Schumer later told Marijuana Moment in an interview that he thought his intervention “had a real effect and New York’s bill, at the end of the day, being a very strong bill, I was very glad to see what they did on expungement.”
Schumer spoke at cannabis legalization rallies in New York City several times—saying at a 2023 event that the federal government needed to catch up with his state’s marijuana legalization law.
He has also leaned into cannabis culture on occasion, taking to the Senate floor on the unofficial stoner holiday 4/20 in 2021 to say it was “as appropriate a time as any to take a hard look at our laws that have over-criminalized the use of marijuana and put it on a par with heroin, LSD and other narcotics that bear little or no resemblance in their effect either on individuals or on society more broadly.”
“The war on drugs has too often been a war on people, particularly people of color,” he said in the speech. “Hopefully the next time this unofficial holiday 4/20 rolls around, our country will have made progress in addressing the massive over-criminalization of marijuana in a meaningful and comprehensive way.”
He also spoke at a cannabis policy summit on 4/20 in 2023.
The senator has joined colleagues in signing a number of letters pushing federal officials for marijuana reforms, including rescheduling.
Schumer has also celebrated advancements toward rescheduling marijuana under both the Biden and Trump administrations, and he cheered Biden’s moves to grant clemency to people who have committed cannabis offenses.
In 2018, Schumer criticized a move by President Donald Trump’s first attorney general to rescind marijuana enforcement guidance that was issued during the Obama administration.
The senator appeared on the podcast of former Drug Policy Alliance Executive Director Ethan Nadelmann in 2021, discussing his legislative strategy around cannabis but saying he has never used it himself.
“I believe that just because I didn’t, people should make their choices and not have the government, particularly in a crazy legal system and criminal justice system, impose it,” he said, adding that he was “in the minority” of his peers in college who have never indulged.
Schumer has also noted broad public support for marijuana reform, including by highlighting polls that show bipartisan backing for legalization.
The senator’s intense marijuana reform advocacy in the late 2010s and early 2020s was seen as notable by longtime legalization advocates given his prior general support for criminalization-focused approaches to drugs during his time on Capitol Hill, including when as a member of the Houser of Representatives he cosponsored the Anti-Drug Abuse Act of 1986, which established harsh mandatory minimum sentences.
While there weren’t many significant cannabis-focused votes during his time in the House, Schumer did not participate in a 1998 vote on a resolution expressing “the sense of Congress that marijuana is a dangerous and addictive drug and should not be legalized for medicinal use.”
Meanwhile, Schumer’s focus on the need to reform federal marijuana laws does seem to have waned considerably over the last few years.
Although he did join other Democratic senators in refiling their comprehensive legalization bill in the current Congress this year, they did not hold a press event about it and Schumer did not conduct interviews focused on his as he did for past iterations.
A review of Schumer’s social media feeds also shows he has made significantly fewer posts about cannabis since 2024.
Sen. Chris Van Hollen (D-MD)
As a senator, Van Hollen has not joined other Democrats in cosponsoring the federal marijuana legalization bills that Schumer has championed, but he has separately called for broad descheduling of cannabis.
He has also signed on to more limited medical cannabis-focused proposals to protect people acting in accordance with state laws from federal criminalization and to encourage the Department of Veterans Affairs (VA) to research the therapeutic benefits of marijuana for military veterans.
In 2023, Van Hollen voted to support a bill to increase marijuana businesses’ access to banks during a markup in the Senate Banking, Housing and Urban Affairs Committee, saying it is “an important step forward in eliminating the cash economy and all the the risks and burdens that comes with that in an area that is legal in many states, including my state of Maryland.”
He added, however, that he agreed with another lawmaker’s concerns about advancing the industry-focused reform while criminalization remains in place—saying that if the panel had jurisdiction on criminal justice aspects of cannabis, he would not vote to move the banking bill forward without addressing those issues.
Last year, Van Hollen voted to table an amendment that would have removed provisions from spending legislation to federally recriminalize hemp THC products, explaining that he’s “concerned that existing federal law creates the opportunity for unregulated and intoxicating synthetic hemp products to be marketed and sold to children.”
But he left the door open to supporting future reforms around hemp, saying that Congress should “ensure a sustainable pathway forward for safe hemp products like CBD, which many people depend on to safely manage pain and other health conditions.”
This year, he supported a motion to table an amendment that would have stripped language from a different bill to delay the implementation of the hemp ban.
The senator sponsored a bill to lift a ban preventing people with certain drug convictions from utilizing an education-related tax credit.
Van Hollen also cosponsored a resolution condemning the arrests of American citizens in Russia, including a Pennsylvania medical cannabis patient, Marc Fogel, who was serving a 14-year sentence over simple possession of marijuana.
The senator has additionally, however, cosponsored a youth online safety bill that could create complications for advertisers trying to promote legal marijuana and other regulated substances.
While previously serving in the House of Representatives, Van Hollen cosponsored bills to shield state-legal medical marijuana activity from federal prosecution, let VA doctors issue medical cannabis recommendations, exclude CBD-rich plants from the definition of illegal marijuana and legalize industrial hemp.
Van Hollen also consistently voted for marijuana reform amendments on the House floor. That includes measures to protect state medical marijuana laws in 2003, 2004, 2005, 2006, 2007, 2012, 2014 and 2015.
In 2015, he also backed an amendment to expand that protection to cover all state marijuana laws, including those allowing recreational use, as well as a separate measure focused on state CBD programs.
On three occasions, Van Hollen voted for amendments to allow VA doctors to recommend medical cannabis to their military veteran patients.
In 2014, he voted for an amendment aimed at increasing marijuana businesses’ access to banking services.
Van Hollen also voted in favor of a number of hemp-related amendments on the House floor.
In 2023, the senator joined a letter calling on the Treasury Department to update federal guidance to prevent financial institutions from discriminating against marijuana business owners over prior cannabis-related activity that’s since been made legal at the state level.
In 2024, Van Hollen joined a sign-on letter with colleagues calling on Biden administration officials to fully deschedule marijuana, saying that a more incremental rescheduling reform “would do little to rectify the most severe harms of the current system.”
“Many of the CSA’s criminal penalties for marijuana will continue as long as marijuana remains in the CSA, because those penalties are based on the quantity of marijuana involved, not the drug’s schedule status. Thus, criminal penalties (including prison sentences, fines, and asset forfeiture) for recreational marijuana use, and medical use of marijuana products that lack federal approval, would still exist, disproportionately penalizing Black and Brown communities… These harms could be remedied only through fully descheduling marijuana. Once descheduled, marijuana can still be subject to public health regulations, drawing from lessons learned through the regulation of alcohol and tobacco.”
Van Hollen cheered then-President Joe Biden’s move to pardon people who have committed federal marijuana possession offenses.
He later praised a state-level cannabis clemency move in his home state by Maryland Gov. Wes Moore (D).
In 2025, Van Hollen signed a letter urging Senate leadership not to advance provisions to recriminalize hemp THC products, despite his vote weeks later in support of keeping such a ban in a spending bill.
In 2018, the senator criticized a Republican-led rider to block local officials in Washington, D.C. from legalizing recreational marijuana sales, saying that “you may like [cannabis legalization] or not like that, but the reality is it’s legal in the District of Columbia so what the mayor and the county council want to do is regulate it.”
“Right now it’s legal but it’s lawless. There are no regulations,” he said, arguing that the policy benefits “bad guys” in the illicit market.
In 2018, Van Hollen criticized a decision by President Donald Trump’s first attorney general to rescind Obama-era guidance that generally urged federal prosecutors not to pursue cases against people acting in accordance with state marijuana laws.
Senate Democrats are set to hold a vote on the leadership election between Schumer and Van Hollen on December 1, though some members of the party have spoken about moving the vote up.
Meanwhile, Senate and House Republicans recently elected leaders who strongly oppose marijuana reforms, including legalization, rescheduling and industry banking access.














